{"rows":[{"id":6029,"title":"Sex-related differences in outcomes following psilocybin or escitalopram: a Bayesian secondary analysis","authors":"Frick Aline, Blest-Hopley Grace, Girn Manesh, Erritzoe David, Nutt David, Carhart-Harris Robin","journal":"Psychopharmacology","publication_date":"2026-10-26","publication_year":2026,"doi":"10.1007/s00213-026-07177-7","pubmed_id":"42931904","openalex_id":null,"source_url":"https://doi.org/10.1007/s00213-026-07177-7","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Wellbeing,Clinical Trial,Randomized Controlled Trial,Drug Interactions","study_type":"Randomized Controlled Trial","source_name":"Crossref","publication_status":"published","date_added":"2026-10-27 02:20:04","last_checked":"2026-10-27 02:20:16","bibtex":null,"source_record_id":"PMID:42931904","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1007/s00213-026-07177-7","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42931904","source_url":"https://doi.org/10.1007/s00213-026-07177-7","doi":"10.1007/s00213-026-07177-7","pmid":"42931904","publication_date":"2026-10-26","importer_version":"2.1.3","text_redistributed":false}},{"id":5676,"title":"Psilocybin therapy for adult females with anorexia nervosa: pilot study","authors":"Douglass Hannah M., Spriggs Meg J., Godfrey Kate, Danby Jennifer L., de Magalhaes Frederico J. C., Macdonald Lauren, Alderton Kirsty L., Archer Stephanie, Ahmad Kirran, Martell Jonny, Frias Jennifer T., Sawicka Gabriela, Read Tim, Blemings Allan, Lafrance Adele, Nicholls Dasha, Erritzoe David, Park Rebecca J., Nutt David J., Carhart-Harris Robin L.","journal":"The British Journal of Psychiatry","publication_date":"2026-07-08","publication_year":2026,"doi":"10.1192/bjp.2026.10687","pubmed_id":"42414058","openalex_id":"https://openalex.org/W7167587921","source_url":"https://doi.org/10.1192/bjp.2026.10687","substance_tags":"psilocybin","topic_tags":"Eating Disorders,Headache / Migraine,Clinical Trial,Safety,Adverse Events","study_type":"Clinical Trial","source_name":"Crossref","publication_status":"published","date_added":"2026-07-08 01:20:22","last_checked":"2026-08-09 08:28:46","bibtex":null,"source_record_id":"PMID:42414058","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1192/bjp.2026.10687","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42414058","source_url":"https://doi.org/10.1192/bjp.2026.10687","doi":"10.1192/bjp.2026.10687","pmid":"42414058","publication_date":"2026-07-08","importer_version":"2.1.3","text_redistributed":false}},{"id":5659,"title":"Psychedelics: reconnecting the brain to heal the mind","authors":"David Nutt","journal":"The Biochemist","publication_date":"2024-03-25","publication_year":2024,"doi":"10.1042/bio_2023_156","pubmed_id":null,"openalex_id":"https://openalex.org/W4393157656","source_url":"https://doi.org/10.1042/bio_2023_156","substance_tags":"psilocybin","topic_tags":"Depression,Addiction,Receptor Pharmacology,Healthy Volunteers,Treatment-Resistant Depression","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:52:11","last_checked":"2026-08-09 08:26:01","bibtex":null,"source_record_id":"DOI:10.1042/bio_2023_156","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1042/bio_2023_156","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1042/bio_2023_156","source_url":"https://doi.org/10.1042/bio_2023_156","doi":"10.1042/bio_2023_156","pmid":"","publication_date":"2024-03-25","importer_version":"2.1.3","text_redistributed":false}},{"id":5333,"title":"P.1.e.017 The functional brain correlates of the psychedelic state: an arterial spin labelling study with psilocybin","authors":"Robin Carhart-Harris, David Erritzøe, James Stone, Rjs Wise, David Nutt","journal":"European Neuropsychopharmacology","publication_date":"2011-08-07","publication_year":2011,"doi":"10.1016/s0924-977x(11)70495-3","pubmed_id":null,"openalex_id":"https://openalex.org/W2061147949","source_url":"https://doi.org/10.1016/s0924-977x(11)70495-3","substance_tags":"psilocybin","topic_tags":"Mechanism of Action,Cancer Patients","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:52:05","last_checked":"2026-08-09 08:25:54","bibtex":null,"source_record_id":"DOI:10.1016/s0924-977x(11)70495-3","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/s0924-977x(11)70495-3","source_url":"https://doi.org/10.1016/s0924-977x(11)70495-3","doi":"10.1016/s0924-977x(11)70495-3","pmid":"","publication_date":"2011-08-07","importer_version":"2.1.3","text_redistributed":false}},{"id":5268,"title":"5HT2a Receptors - a New Target for Depression?","authors":"D.J. Nutt","journal":"European Psychiatry","publication_date":"2015-03-01","publication_year":2015,"doi":"10.1016/s0924-9338(15)30027-4","pubmed_id":null,"openalex_id":"https://openalex.org/W562065783","source_url":"https://doi.org/10.1016/s0924-9338(15)30027-4","substance_tags":"psilocybin","topic_tags":"Depression,Receptor Pharmacology,Default Mode Network","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:52:04","last_checked":"2026-08-09 08:25:53","bibtex":null,"source_record_id":"DOI:10.1016/s0924-9338(15)30027-4","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1016/s0924-9338(15)30027-4","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/s0924-9338(15)30027-4","source_url":"https://doi.org/10.1016/s0924-9338(15)30027-4","doi":"10.1016/s0924-9338(15)30027-4","pmid":"","publication_date":"2015-03-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5226,"title":"Tripping up addiction: the use of psychedelic drugs in the treatment of problematic drug and alcohol use","authors":"Celia J. A. Morgan, Amy McAndrew, Tobias Stevens, David Nutt, Will Lawn","journal":"Current Opinion in Behavioral Sciences","publication_date":"2016-11-14","publication_year":2016,"doi":"10.1016/j.cobeha.2016.10.009","pubmed_id":null,"openalex_id":"https://openalex.org/W2557014604","source_url":"https://doi.org/10.1016/j.cobeha.2016.10.009","substance_tags":"psilocybin","topic_tags":"Addiction,Pharmacology,Receptor Pharmacology","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:52:03","last_checked":"2026-07-04 06:52:03","bibtex":null,"source_record_id":"DOI:10.1016/j.cobeha.2016.10.009","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.cobeha.2016.10.009","source_url":"https://doi.org/10.1016/j.cobeha.2016.10.009","doi":"10.1016/j.cobeha.2016.10.009","pmid":"","publication_date":"2016-11-14","importer_version":"2.1.3","text_redistributed":false}},{"id":5202,"title":"Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant Depression","authors":"Rosalind Watts, Camilla Day, Jacob Krzanowski, David Nutt, Robin Carhart-Harris","journal":"Journal of Humanistic Psychology","publication_date":"2017-06-19","publication_year":2017,"doi":"10.1177/0022167817709585","pubmed_id":null,"openalex_id":"https://openalex.org/W2644260506","source_url":"https://doi.org/10.1177/0022167817709585","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Emotional Processing,Treatment-Resistant Depression","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:52:02","last_checked":"2026-08-09 08:25:51","bibtex":null,"source_record_id":"DOI:10.1177/0022167817709585","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1177/0022167817709585","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1177/0022167817709585","source_url":"https://doi.org/10.1177/0022167817709585","doi":"10.1177/0022167817709585","pmid":"","publication_date":"2017-06-19","importer_version":"2.1.3","text_redistributed":false}},{"id":5049,"title":"Psychedelic experience dose-dependently modulated by cannabis: results of a prospective online survey","authors":"Joanna Kuc, Hannes Kettner, Fernando E. Rosas, David Erritzøe, Eline Haijen, Mendel Kaelen, David Nutt, Robin Carhart-Harris","journal":"Psychopharmacology","publication_date":"2021-11-03","publication_year":2021,"doi":"10.1007/s00213-021-05999-1","pubmed_id":"34734314","openalex_id":"https://openalex.org/W3208662682","source_url":"https://doi.org/10.1007/s00213-021-05999-1","substance_tags":"psilocybin","topic_tags":"Chronic Pain,Consciousness,Emotional Processing,Mystical Experience,Observational Study,Toxicity,Drug Interactions","study_type":"Observational Study","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:51:58","last_checked":"2026-07-04 06:51:58","bibtex":null,"source_record_id":"PMID:34734314","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1007/s00213-021-05999-1","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"PMID:34734314","source_url":"https://doi.org/10.1007/s00213-021-05999-1","doi":"10.1007/s00213-021-05999-1","pmid":"34734314","publication_date":"2021-11-03","importer_version":"2.1.3","text_redistributed":false}},{"id":5038,"title":"P.0353 Study protocol: psilocybin as a treatment for anorexia nervosa: a pilot study","authors":"Hannah Douglass, Meg J. Spriggs, R.J. Park, Tim Read, Jennifer L. Danby, Frederico José Coelho de Magalhães, Kirsty L. Alderton, Adèle Lafrance, Dasha Nicholls, David Erritzøe, David Nutt, Robin Carhart-Harris","journal":"European Neuropsychopharmacology","publication_date":"2021-12-01","publication_year":2021,"doi":"10.1016/j.euroneuro.2021.10.335","pubmed_id":null,"openalex_id":"https://openalex.org/W4200393290","source_url":"https://doi.org/10.1016/j.euroneuro.2021.10.335","substance_tags":"psilocybin","topic_tags":"Eating Disorders,Receptor Pharmacology","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:51:58","last_checked":"2026-08-09 08:25:44","bibtex":null,"source_record_id":"DOI:10.1016/j.euroneuro.2021.10.335","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.euroneuro.2021.10.335","source_url":"https://doi.org/10.1016/j.euroneuro.2021.10.335","doi":"10.1016/j.euroneuro.2021.10.335","pmid":"","publication_date":"2021-12-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5033,"title":"P.0885 The effect of psilocybin therapy for depression on low-frequency brain activity in response to music","authors":"Matthew B. Wall, Cynthia Lam, Natalie Ertl, Mendel Kaelen, Leor Roseman, David Nutt, Robin Carhart-Harris","journal":"European Neuropsychopharmacology","publication_date":"2021-12-01","publication_year":2021,"doi":"10.1016/j.euroneuro.2021.10.741","pubmed_id":null,"openalex_id":"https://openalex.org/W4200025628","source_url":"https://doi.org/10.1016/j.euroneuro.2021.10.741","substance_tags":"psilocybin","topic_tags":"Depression,Receptor Pharmacology","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:51:58","last_checked":"2026-08-09 08:25:44","bibtex":null,"source_record_id":"DOI:10.1016/j.euroneuro.2021.10.741","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.euroneuro.2021.10.741","source_url":"https://doi.org/10.1016/j.euroneuro.2021.10.741","doi":"10.1016/j.euroneuro.2021.10.741","pmid":"","publication_date":"2021-12-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5003,"title":"Raising awareness: The implementation of medical cannabis and psychedelics used as an adjunct to standard therapy in the treatment of advanced metastatic breast cancer","authors":"Rayyan Zafar, Dustin Sulak, Jaime Brambila, David Nutt, Anne Katrin Schlag","journal":"Drug Science Policy and Law","publication_date":"2022-01-01","publication_year":2022,"doi":"10.1177/20503245221114323","pubmed_id":null,"openalex_id":"https://openalex.org/W4296882666","source_url":"https://doi.org/10.1177/20503245221114323","substance_tags":"psilocybin","topic_tags":"End-of-Life Distress,Chronic Pain,Pharmacology,Cancer Patients","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:51:58","last_checked":"2026-08-09 08:25:43","bibtex":null,"source_record_id":"DOI:10.1177/20503245221114323","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1177/20503245221114323","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1177/20503245221114323","source_url":"https://doi.org/10.1177/20503245221114323","doi":"10.1177/20503245221114323","pmid":"","publication_date":"2022-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4927,"title":"Molecular Structure, Reactivity and Spectroscopic Properties of Hallucinogens Psilocybin, Mescaline and their Derivatives - A Computational Study","authors":"Gomathi Saminathan, Kavitha Kandasamy, Savitha Navaneethakrishnan, Mohana Ashokkumar, Brindha Veerappan, Krishnamoorthy Bellie Sundaram, G Aghajanian, G Marek, J.-C Bque, M Imad, L Mladenovic, J Gingrich, R Andrade, R Glennon, J Rosecrans, R Young, C Krumhansl, E Kessler, D Nichols, Psychedelics, Hallucinogens, P Delgado, F Moreno, C Nichols, B Liester, R Strassman, L Roseman, L Demetriou, M Wall, D Nutt, R Carhart-Harris, B Krishnamoorthy, S Kahlal, S Ghosh, J.-F Halet, Electronic, A Thakur, K Chakrahari, S Bose, P Hamon, T Roisnel, B Le Guennic, J.-Y Saillard, K Geetharani, S Mobin, F Neese, A Sherwood, R Kargbo, K Kaylo, N Cozzi, P Meisenheimer, J Kaduk, J Daniel, M Haberman, T Prisinzano, P Cumming, M Scheidegger, D Dornbierer, M Palner, B Quednow, C Martin-Soelch, A Rickli, O Moning, M Hoener, M Liechti, M Madsen, D Stenbaek, A Arvidsson, S Armand, M Marstrand-Joergensen, S Johansen, K Linnet, B Ozenne, G Knudsen, P Fisher, E Pottie, O Kupriyanova, A Brandt","journal":"Letters in Applied NanoBioScience","publication_date":"2022-09-17","publication_year":2022,"doi":"10.33263/lianbs124.105","pubmed_id":null,"openalex_id":"https://openalex.org/W4308468771","source_url":"https://doi.org/10.33263/lianbs124.105","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:51:56","last_checked":"2026-08-09 08:25:40","bibtex":null,"source_record_id":"DOI:10.33263/lianbs124.105","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.33263/lianbs124.105","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.33263/lianbs124.105","source_url":"https://doi.org/10.33263/lianbs124.105","doi":"10.33263/lianbs124.105","pmid":"","publication_date":"2022-09-17","importer_version":"2.1.3","text_redistributed":false}},{"id":4866,"title":"Psilocybin as a treatment for anorexia nervosa: 6-week and 3-month follow-up results","authors":"Hannah Douglass, Merle Spriggs, Kate Godfrey, Jennifer L. Danby, Francisco Magalhães, Kirsty L. Alderton, Liane Macdonald, Stephanie Archer, Tim Read, Adèle Lafrance, Dasha Nicholls, David Erritzøe, R. Park, David Nutt, Robin Carhart-Harris","journal":"Neuroscience Applied","publication_date":"2023-01-01","publication_year":2023,"doi":"10.1016/j.nsa.2023.102878","pubmed_id":null,"openalex_id":"https://openalex.org/W4390223843","source_url":"http://dx.doi.org/10.1016/j.nsa.2023.102878","substance_tags":"psilocybin","topic_tags":"Eating Disorders","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:46","last_checked":"2026-08-09 08:25:38","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2023.102878","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2023.102878","source_url":"http://dx.doi.org/10.1016/j.nsa.2023.102878","doi":"10.1016/j.nsa.2023.102878","pmid":"","publication_date":"2023-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4826,"title":"Psychedelic Medicine: From Brain Science to Clinical Trials","authors":"David Nutt","journal":"Biological Psychiatry","publication_date":"2023-04-09","publication_year":2023,"doi":"10.1016/j.biopsych.2023.02.022","pubmed_id":null,"openalex_id":"https://openalex.org/W4363673488","source_url":"http://dx.doi.org/10.1016/j.biopsych.2023.02.022","substance_tags":"psilocybin","topic_tags":"Addiction,Brain Imaging,Receptor Pharmacology,Default Mode Network,Aging,Clinical Trial","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:46","last_checked":"2026-07-04 06:34:46","bibtex":null,"source_record_id":"DOI:10.1016/j.biopsych.2023.02.022","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.biopsych.2023.02.022","source_url":"http://dx.doi.org/10.1016/j.biopsych.2023.02.022","doi":"10.1016/j.biopsych.2023.02.022","pmid":"","publication_date":"2023-04-09","importer_version":"2.1.3","text_redistributed":false}},{"id":4667,"title":"Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive Disorder","authors":"Brandon Weiss, Leor Roseman, Bruna Giribaldi, David Nutt, Robin Carhart-Harris, David Erritzøe","journal":"International Journal of Mental Health and Addiction","publication_date":"2024-03-07","publication_year":2024,"doi":"10.1007/s11469-024-01253-9","pubmed_id":null,"openalex_id":"https://openalex.org/W4392550813","source_url":"https://doi.org/10.1007/s11469-024-01253-9","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Mystical Experience,Clinical Trial,Treatment-Resistant Depression","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:43","last_checked":"2026-08-09 08:25:30","bibtex":null,"source_record_id":"DOI:10.1007/s11469-024-01253-9","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1007/s11469-024-01253-9","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1007/s11469-024-01253-9","source_url":"https://doi.org/10.1007/s11469-024-01253-9","doi":"10.1007/s11469-024-01253-9","pmid":"","publication_date":"2024-03-07","importer_version":"2.1.3","text_redistributed":false}},{"id":4475,"title":"Effects of escitalopram and psilocybin therapy on mesolimbic resting-state functional connectivity in depression","authors":"Rebecca Harding, Natalie Ertl, Rabia Zafar, Magnus Wall, Rajkanya Das, David Erritzøe, David Nutt, Robin Carhart-Harris","journal":"Neuroscience Applied","publication_date":"2025-01-01","publication_year":2025,"doi":"10.1016/j.nsa.2025.105421","pubmed_id":null,"openalex_id":"https://openalex.org/W4408526135","source_url":"https://doi.org/10.1016/j.nsa.2025.105421","substance_tags":"psilocybin","topic_tags":"Depression,Brain Imaging","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:41","last_checked":"2026-08-09 08:25:24","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2025.105421","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2025.105421","source_url":"https://doi.org/10.1016/j.nsa.2025.105421","doi":"10.1016/j.nsa.2025.105421","pmid":"","publication_date":"2025-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4303,"title":"A lexicon for psychedelic research and treatment","authors":"David Nutt, David Erritzøe, Anne Katrin Schlag, David Luke, Deborah C. Mash, Hiroyuki Uchida, Jacob S. Aday, James Rucker, Liliana Galindo, Mark Sweeney, Matthew X. Lowe, Oliver Davis, Plinio Ferreira, Rayyan Zafar, Robin Carhart-Harris, Tadeusz Hawrot, Joanna C. Neill","journal":"Drug Science Policy and Law","publication_date":"2025-08-31","publication_year":2025,"doi":"10.1177/20503245251380511","pubmed_id":null,"openalex_id":"https://openalex.org/W4414407628","source_url":"https://doi.org/10.1177/20503245251380511","substance_tags":"psilocybin","topic_tags":"Depression,Pharmacology,Microdosing,Clinical Trial,Treatment-Resistant Depression,Safety","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:39","last_checked":"2026-07-04 07:00:33","bibtex":null,"source_record_id":"DOI:10.1177/20503245251380511","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1177/20503245251380511","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1177/20503245251380511","source_url":"https://doi.org/10.1177/20503245251380511","doi":"10.1177/20503245251380511","pmid":"","publication_date":"2025-08-31","importer_version":"2.1.3","text_redistributed":false}},{"id":3905,"title":"P.609 Therapeutic mechanisms of psychedelic drugs: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression","authors":"Laura Mertens, M.B. Wall, L. Roseman, L. Demetriou, D.J. Nutt, R.L. Carhart-Harris","journal":"European Neuropsychopharmacology","publication_date":"2019-12-01","publication_year":2019,"doi":"10.1016/j.euroneuro.2019.09.593","pubmed_id":null,"openalex_id":"https://openalex.org/W4248055189","source_url":"https://doi.org/10.1016/j.euroneuro.2019.09.593","substance_tags":"psilocybin","topic_tags":"Depression,Mechanism of Action,Emotional Processing,Clinical Trial,Treatment-Resistant Depression","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-02 20:42:13","last_checked":"2026-08-09 08:25:49","bibtex":null,"source_record_id":"DOI:10.1016/j.euroneuro.2019.09.593","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.euroneuro.2019.09.593","source_url":"https://doi.org/10.1016/j.euroneuro.2019.09.593","doi":"10.1016/j.euroneuro.2019.09.593","pmid":"","publication_date":"2019-12-01","importer_version":"2.1.3","text_redistributed":false}},{"id":3881,"title":"Improved colour blindness symptoms associated with recreational psychedelic use: Results from the Global Drug Survey 2017","authors":"JEC Anthony, Adam Winstock, JA Ferris, DJ Nutt","journal":"Drug Science Policy and Law","publication_date":"2020-01-01","publication_year":2020,"doi":"10.1177/2050324520942345","pubmed_id":null,"openalex_id":"https://openalex.org/W3096479563","source_url":"https://doi.org/10.1177/2050324520942345","substance_tags":"psilocybin","topic_tags":"Receptor Pharmacology,Observational Study","study_type":"Observational Study","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-02 20:42:13","last_checked":"2026-08-09 08:25:49","bibtex":null,"source_record_id":"DOI:10.1177/2050324520942345","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1177/2050324520942345","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1177/2050324520942345","source_url":"https://doi.org/10.1177/2050324520942345","doi":"10.1177/2050324520942345","pmid":"","publication_date":"2020-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":3770,"title":"A critique of: Skepticism About Recent Evidence that Psilocybin Opens Depressed Minds","authors":"Carhart-Harris R, Daws RE, Nutt D.","journal":"PsyArXiv","publication_date":"2022-05-10","publication_year":2022,"doi":"10.31234/osf.io/pdbf5","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.31234/osf.io/pdbf5","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"PsyArXiv","publication_status":"preprint","date_added":"2026-07-01 11:10:20","last_checked":"2026-08-09 08:15:12","bibtex":null,"source_record_id":"DOI:10.31234/osf.io/pdbf5","abstract_available":true,"abstract_source":"PsyArXiv","abstract_source_url":"https://doi.org/10.31234/osf.io/pdbf5","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/pdbf5","source_url":"https://doi.org/10.31234/osf.io/pdbf5","doi":"10.31234/osf.io/pdbf5","pmid":"","publication_date":"2022-05-10","importer_version":"2.1.3","text_redistributed":false}}],"total":131,"page":1,"per_page":20,"pages":7,"resource":"papers","filters":{"q":null,"author":"David Nutt","substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":null,"from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}